Abstract: A pacifier is provided with an enlarged guard to rest against a premature baby's lips, and a nipple with a base, a narrow neck, and a bulbous tip. A hole is provided in the guard, and communicates with an open channel or pathway formed on the exterior surface of the nipple base. Milk drops from a syringe or other source can be introduced through the hole to the channel, and then flow into the baby's mouth. This introduction of milk along the pacifier into the premature infant's mouth helps the premature infant to learn sucking and swallowing, even while being fed through a nasal tube.

Abstract: The apparatus and process described, allows the premature infant to continue the enjoyable in utero experience of sucking and swallowing that is halted upon birth. In particular the infant is afforded the opportunity to practice tasting, sucking, and swallowing on an individualized basis. This oral enjoyment and practice allow for positive association with feedings and provides a sensory-motor experience that may lead to earlier suck, swallow, breathe (SSB) synchrony. The process engages the esophagus and cardiac sphincter to function while the infant is still being fed through the feeding rube. Ultimately, the apparatus and process may also result in earlier weaning from feeding tubes, the reduction of feeding difficulties, and earlier discharge home.

Abstract: A hanging corner shelf assembly is provided which includes a first member and a second member, which diverge from one another. Each member includes a first side and a second side, an inner side and an outer side. The first and second members are configured for attachment to one another. The hanging corner shelf assembly further includes at least one shelf member extending from the first member and the second member, wherein a longitudinal axis of the at least one shelf member is generally perpendicularly oriented relative to a longitudinal axis of each of the first and second members and at least one hanging member is included, wherein the at least one hanging member is engageable to the first and/or second member.

Abstract: A hanging corner shelf assembly is provided which includes a first member and a second member, which diverge from one another. Each member includes a first side and a second side, an inner side and an outer side. The first and second members are configured for attachment to one another. The hanging corner shelf assembly further includes at least one shelf member extending from the first member and the second member, wherein a longitudinal axis of the at least one shelf member is generally perpendicularly oriented relative to a longitudinal axis of each of the first and second members and at least one hanging member is included, wherein the at least one hanging member is engageable to the first and/or second member.

Abstract: Isolated nucleic acid molecules having a nucleotide sequence encoding feline pancreatic lipase polypeptides, splice variants, allelic variants, and fragments thereof. Isolated feline pancreatic lipase polypeptides, splice variants, allelic variants, and fragments thereof. Host cells comprising a vector containing the polynucleotide sequences and methods for expressing the polypeptides. The generation of monoclonal antibodies that specifically binds to the feline pancreatic lipase polypeptides, and cell lines secreting the monoclonal antibodies. Methods for determining the presence or amount of feline pancreatic lipase in a biological sample. The methods include using standards or calibrators of recombinant feline pancreatic lipase to quantify the lipase in a sample. Devices and kits for performing methods for detecting feline pancreatic lipase in biological samples.

Abstract: Isolated nucleic acid molecules having a nucleotide sequence encoding feline pancreatic lipase polypeptides, splice variants, allelic variants, and fragments thereof. Isolated feline pancreatic lipase polypeptides, splice variants, allelic variants, and fragments thereof. Host cells comprising a vector containing the polynucleotide sequences and methods for expressing the polypeptides. The generation of monoclonal antibodies that specifically binds to the feline pancreatic lipase polypeptides, and cell lines secreting the monoclonal antibodies. Methods for determining the presence or amount of feline pancreatic lipase in a biological sample. The methods include using standards or calibrators of recombinant feline pancreatic lipase to quantify the lipase in a sample. Devices and kits for performing methods for detecting feline pancreatic lipase in biological samples.

Abstract: Isolated nucleic acid molecules having a nucleotide sequence encoding feline pancreatic lipase polypeptides, splice variants, allelic variants, and fragments thereof. Isolated feline pancreatic lipase polypeptides, splice variants, allelic variants, and fragments thereof. Host cells comprising a vector containing the polynucleotide sequences and methods for expressing the polypeptides. The generation of monoclonal antibodies that specifically binds to the feline pancreatic lipase polypeptides, and cell lines secreting the monoclonal antibodies. Methods for determining the presence or amount of feline pancreatic lipase in a biological sample. The methods include using standards or calibrators of recombinant feline pancreatic lipase to quantify the lipase in a sample. Devices and kits for performing methods for detecting feline pancreatic lipase in biological samples.

Abstract: Isolated nucleic acid molecules having a nucleotide sequence encoding feline pancreatic lipase polypeptides, splice variants, allelic variants, and fragments thereof. Isolated feline pancreatic lipase polypeptides, splice variants, allelic variants, and fragments thereof. Host cells comprising a vector containing the polynucleotide sequences and methods for expressing the polypeptides. The generation of monoclonal antibodies that specifically binds to the feline pancreatic lipase polypeptides, and cell lines secreting the monoclonal antibodies. Methods for determining the presence or amount of feline pancreatic lipase in a biological sample. The methods include using standards or calibrators of recombinant feline pancreatic lipase to quantify the lipase in a sample. Devices and kits for performing methods for detecting feline pancreatic lipase in biological samples.

Abstract: A self-adhesive laminate with an emissivity of no greater than about 0.40 made of a sheet layer having first and second outer surfaces, the sheet layer comprising at least one layer selected from the group consisting of nonwoven fabrics, woven fabrics, nonwoven fabric-film laminates, woven fabric-film laminates, films, paper-film laminates, and composites thereof with at least one multi-layer coating on said first outer surface of the sheet layer, said multi-layer coating comprising a first metal coating layer adjacent the first outer surface of the sheet layer; and an outer organic coating layer of a composition containing a material selected from the group consisting of organic polymers, organic oligomers, compounds, and combinations thereof, deposited on the metal layer; and with an adhesive layer coating the second outer surface of the sheet layer and wherein the sheet layer coated with said multilayer coating is creped.

Abstract: An elongated flange material for forming a flange and a method for use in sealing a non-flanged window, door, or other fenestration product in a wall opening, wherein the flange material comprises at least one top coversheet and at least one bottom coversheet with a pressure-sensitive adhesive layer sandwiched between the two coversheets, wherein the coversheets occupy an appreciable width of the flange but do not extend across the entire width of the flange and thereby are offset with respect to each other thereby providing opposing first and second exposed surfaces of the pressures sensitive adhesive layer. Alternatively, the flange material comprises a nonporous flexible sheet with top and bottom pressure-sensitive adhesive layer on opposite sides along opposite edges of the nonporous flexible sheet.

Abstract: A stable pharmaceutically acceptable aqueous formulation containing human growth hormone, a buffer, a non-ionic surfactant, and, optionally, a neutral salt, mannitol, or, a preservative, is disclosed. Also disclosed are associated means and methods for preparing, storing, and using such formulations.

Abstract: An elongated flange material for forming a flange and a method for use in sealing a non-flanged window, door, or other fenestration product in a wall opening, wherein the flange material comprises at least one top coversheet and at least one bottom coversheet with a pressure-sensitive adhesive layer sandwiched between the two coversheets, wherein the coversheets occupy an appreciable width of the flange but do not extend across the entire width of the flange and thereby are offset with respect to each other thereby providing opposing first and second exposed surfaces of the pressures sensitive adhesive layer.

Abstract: An air infiltration blocking skirt comprising a weather resistant sheet material is attached to the lower portion of a window to be installed in a wall opening the full width of the opening and sufficiently long to extend over the wall immediately below the window. The skirt is sealed to the wall along both the left and right sides of the skirt while the bottom edge remains unsealed. The skirt prevents wind-driven rain and air from penetrating the window-wall interface while allowing moisture to drain therethrough.

Abstract: The methods for determining the probability of detection of a thermally camouflaged target at various ranges by the sensor includes determining an “inherent” temperature difference, ?TRSS, between the target and its immediate surroundings. Once ?TRSS is determined, a scaled N50 cycle criterion, or the number of resolvable cycles needed by the sensor for a fifty percent probability of detection, is determined according to the relationship N50=A/(?TRSS)B+C, where A, B and C are constants that are predetermined according to whether the immediate surroundings are of a woodland or a littoral nature. The scaled N50 cycle criterion is then used in an empirical Target Transfer Probability Function (TTPF) defined by P=(N/N50)E/(1+(N/N50)E), where E=2.7+0.7(N/N50), in order to determine the probability of detection of the thermally camouflaged target.

Abstract: A stable pharmaceutically acceptable aqueous formulation containing human growth hormone, a buffer, a non-ionic surfactant, and, optionally, a neutral salt, mannitol, or, a preservative, is disclosed. Also disclosed are associated means and methods for preparing, storing, and using such formulations.

Abstract: New compositions formed from the combination of an active substance with a hydrogel carrier moiety are provided. The compositions are suitable for use in high-velocity transdermal particle injection techniques. Methods of providing the new compositions are also provided. In addition, methods for administering pharmacologically active agent to a subject are provided. These methods are useful for delivering drugs, biopharmaceuticals, vaccines and diagnostics agents.

Abstract: A personal care absorbent article, such as an infant diaper, a training pant, an incontinence garment and the like, having at least one swellable structure attached thereto for use as a containment dam or support structure. The swellable structure having a swellable layer and a cover material adapted to expand upon swelling of the swellable layer. The pleated cover material allows the swellable layer to swell freely in a z-direction.

Abstract: A stable aqueous pharmaceutical formulation comprising a therapeutically effective amount of an antibody, polysorbate 80, a buffer which inhibits polysorbate oxidation is described along with methods of making the preparation. Also described are formulations with high antibody concentrations which maintain fixed volumes and which may be used on patients of variable weight.